| Bid | 9.77 |
| Market Cap | 1.57B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.26 |
| PE Ratio (ttm) | -8.79 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 11.8 |
| Volume | 1,523,800 |
| Avg. Volume (20D) | 1,972,357 |
| Open | 11.08 |
| Previous Close | 10.88 |
| Day's Range | 10.81 - 11.18 |
| 52-Week Range | 4.88 - 17.34 |
| Beta | undefined |
About ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and...
Analyst Forecast
According to 9 analyst ratings, the average rating for ATEC stock is "Buy." The 12-month stock price forecast is $18, which is an increase of 62.45% from the latest price.
Next Earnings Release
Analysts project revenue of $170.31M, reflecting a 23.44% YoY growth and earnings per share of -0.07, making a -81.08% decrease YoY.
2 months ago · businesswire.com
ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year GuidanceCARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial resu...